Multimodal Therapeutic Approach for a Severe Case of Kaposiform Lymphangiomatosis: From Procedural Interventions to Targeted Therapies
May 2024
in “
Pediatric Blood & Cancer
”
Studysummary In this case study, a transition to the MEK inhibitor trametinib successfully stabilized disease and reduced toxicity in a patient with refractory kaposiform lymphangiomatosis after prolonged sirolimus and steroid treatment.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →